Reframe Partners with Iform Legal to Offer Peace-of-Mind Planning for Anyone Affected by Cancer
Reframe Cancer has expanded its partner programme to include Iform Legal – specialists in wills, trusts, and future planning.
A cancer diagnosis affects not just the individual but everyone around them. Whether you’re a patient, a carer, or a loved one, legal matters often come to the forefront. That’s why Reframe has partnered with Iform Legal to make future planning clearer, more accessible, and less overwhelming at a time when clarity and peace of mind matter most.
As part of this new partnership, anyone with access to Reframe as a workplace benefit can enjoy:
- 25% off Wills, Trusts, and Lasting Powers of Attorney
- Free expert advice on Powers of Attorney, Will Reviews, Property & Inheritance Protection, and “Peace of Mind Planning”
All employees with access to the Reframe Information Hub can explore Iform Legal’s services and redeem their exclusive discount directly – you do not need to be a Reframe patient to benefit.
Rebecca Huscroft, Founder at Iform Legal, said:
“We understand that arranging Wills, Powers of Attorney, and other Estate Planning matters can feel emotional and overwhelming, which is why so many avoid or delay planning, creating significant financial disruption down the line.
We are here to alleviate anxiety by providing sensitive support to cancer patients and their caregivers, making it easy and simple to address their exact needs and requirements in a convenient and stress-free way.
No matter your age, health, or income, we have affordable solutions to fit all budgets with our 5-star rated service for all.”
Mark Stephenson, CEO of Reframe Cancer, said:
“Our amazing team of experienced cancer nurse specialists and support managers can manage most of our patients’ and customers’ requirements. However, where an additional specialist is required, we have a few external specialists to complement our service. We are delighted to add our 5th specialist, Iform Legal. It’s clear that this is a service that is growing in need, especially for some patients in the later stages of the cancer pathway, and most insurance doesn’t cover this.”